Tapewire

Nasdaq · USD

IRWD

IRONWOOD PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
5213
SEC CIK
0001446847
Parsed reports
478

Last 12 months

Inside the activity.

0 purchase rows · 18 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202601
Feb 2026012
Mar 202602
Apr 202600
May 202600
Jun 202601
Jul 202601
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 29, 2019 Filed May 31, 2019 20:04 UTC GrantClass A Common Stock 22,706 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-033615 · doc4.xml · nonDerivative · entry 1

Currie Mark G · CIK 0001478244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 551,609

F1 · kind: The restricted stock, granted pursuant to the director compensation policy, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.

Read SEC document
May 29, 2019 Filed May 31, 2019 20:08 UTC
Duane Jon RDirector
GrantClass A Common Stock 22,706 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-033624 · doc4.xml · nonDerivative · entry 1

Duane Jon R · CIK 0001772129 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,701

F1 · kind: The restricted stock, granted pursuant to the director compensation policy, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.

Read SEC document
May 29, 2019 Filed May 31, 2019 20:18 UTC GrantClass A Common Stock 22,706 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-033645 · doc4.xml · nonDerivative · entry 1

Owens Edward P · CIK 0001570533 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 182,234

F1 · kind: The restricted stock, granted pursuant to the director compensation policy, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.

Read SEC document
May 29, 2019 Filed May 31, 2019 20:15 UTC GrantClass A Common Stock 22,706 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-033637 · doc4.xml · nonDerivative · entry 1

OLANOFF LAWRENCE S · CIK 0001224341 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,259

F1 · kind: The restricted stock, granted pursuant to the director compensation policy, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.

Read SEC document
May 29, 2019 Filed May 31, 2019 20:13 UTC GrantClass A Common Stock 22,706 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-033633 · doc4.xml · nonDerivative · entry 1

Moukheibir Catherine · CIK 0001772130 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,701

F1 · kind: The restricted stock, granted pursuant to the director compensation policy, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.

Read SEC document
May 29, 2019 Filed May 31, 2019 20:09 UTC GrantClass A Common Stock 22,706 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-033627 · doc4.xml · nonDerivative · entry 1

Kessler Marla L · CIK 0001772124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,701

F1 · kind: The restricted stock, granted pursuant to the director compensation policy, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.

Read SEC document
May 10, 2019 Filed May 14, 2019 16:13 UTC SaleClass A Common Stock 4,055 $10.53 $42,699.15
Disclosure

SEC source: 0001209191-19-029609 · doc4.xml · nonDerivative · entry 1

MCCOURT Thomas A · CIK 0001478448 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,239

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of 100% of the reporting person's restricted stock units granted on July 31, 2018.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.41 to $10.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
May 10, 2019 Filed May 14, 2019 20:10 UTC SaleClass A Common Stock 4,055 $10.53 $42,699.15
Disclosure

SEC source: 0001209191-19-029601 · doc4.xml · nonDerivative · entry 1

Currie Mark G · CIK 0001478244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 528,903

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of 100% of the reporting person's restricted stock units granted on July 31, 2018.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.41 to $10.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
May 10, 2019 Filed May 14, 2019 20:12 UTC
Gilbert Halley EChief Admin Officer & SVP
SaleClass A Common Stock 4,055 $10.53 $42,699.15
Disclosure

SEC source: 0001209191-19-029605 · doc4.xml · nonDerivative · entry 1

Gilbert Halley E · CIK 0001601360 · Chief Admin Officer & SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 238,240

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of 100% of the reporting person's restricted stock units granted on July 31, 2018.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.41 to $10.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
May 10, 2019 Filed May 14, 2019 20:08 UTC
Consylman GinaSVP, CFO & Treasurer
SaleClass A Common Stock 4,055 $10.53 $42,699.15
Disclosure

SEC source: 0001209191-19-029596 · doc4.xml · nonDerivative · entry 1

Consylman Gina · CIK 0001546358 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,860

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of 100% of the reporting person's restricted stock units granted on July 31, 2018.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.41 to $10.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
May 01, 2019 Filed May 3, 2019 16:19 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 45,704 $0.00 Strike: $11.78 $0.00
Disclosure

SEC source: 0001209191-19-027346 · doc4.xml · derivative · entry 2

MCCOURT Thomas A · CIK 0001478448 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,704

Underlying: Class A Common Stock · 45,704 shares

Expires 2029-05-01

F2 · derivative.exercise_date: The options, granted as a promotion grant, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of May 1, 2019.

Read SEC document
May 01, 2019 Filed May 3, 2019 16:19 UTC GrantClass A Common Stock 22,852 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-027346 · doc4.xml · nonDerivative · entry 1

MCCOURT Thomas A · CIK 0001478448 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,294

F1 · kind: The restricted stock units, granted as a promotion award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:04 UTC Disposition to issuerClass A Common Stock 4,056 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-023416 · doc4.xml · nonDerivative · entry 1

MCGUIRE TERRANCE · CIK 0001117003 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,630

F1 · price: Represents the disposition of 4,056 shares of restricted stock in connection with the separation of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. in exchange for restricted shares of Cyclerion Common Stock.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:08 UTC
Hecht Peter MDirector · Chief Executive Officer
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 937,500 Not disclosed Strike: $11.49 Not disclosed
Disclosure

SEC source: 0001209191-19-023427 · doc4.xml · derivative · entry 9

Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Class A Common Stock · 937,500 shares

Expires 2029-01-29

F1 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"). In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F1 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"). In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F1 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"). In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F11 · derivative.exercise_date: The remaining 62,500 shares are presently exercisable in full.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:08 UTC
Hecht Peter MDirector · Chief Executive Officer
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 398,750 Not disclosed Strike: $12.95 Not disclosed
Disclosure

SEC source: 0001209191-19-023427 · doc4.xml · derivative · entry 8

Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 181,250

Underlying: Class A Common Stock · 398,750 shares

Expires 2028-02-21

F1 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"). In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F1 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"). In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F1 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"). In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F10 · derivative.exercise_date: The remaining 181,250 shares are presently exercisable in full.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:08 UTC
Hecht Peter MDirector · Chief Executive Officer
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 332,500 Not disclosed Strike: $14.93 Not disclosed
Disclosure

SEC source: 0001209191-19-023427 · doc4.xml · derivative · entry 7

Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 427,500

Underlying: Class A Common Stock · 332,500 shares

Expires 2027-02-27

F1 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"). In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F1 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"). In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F1 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"). In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F9 · derivative.exercise_date: The remaining 427,500 shares are presently exercisable in full.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:08 UTC
Hecht Peter MDirector · Chief Executive Officer
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 166,875 Not disclosed Strike: $9.12 Not disclosed
Disclosure

SEC source: 0001209191-19-023427 · doc4.xml · derivative · entry 6

Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 723,125

Underlying: Class A Common Stock · 166,875 shares

Expires 2026-03-01

F1 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"). In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F1 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"). In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F1 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"). In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F8 · derivative.exercise_date: The remaining 723,125 shares are presently exercisable in full.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:08 UTC
Hecht Peter MDirector · Chief Executive Officer
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 6,771 Not disclosed Strike: $12.56 Not disclosed
Disclosure

SEC source: 0001209191-19-023427 · doc4.xml · derivative · entry 5

Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 318,229

Underlying: Class A Common Stock · 6,771 shares

Expires 2024-03-03

F7 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 6,771 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock. With respect to the remaining 318,229 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award.

F7 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 6,771 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock. With respect to the remaining 318,229 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award.

F7 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 6,771 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock. With respect to the remaining 318,229 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award.

F4 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:08 UTC
Hecht Peter MDirector · Chief Executive Officer
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 7,645 Not disclosed Strike: $11.65 Not disclosed
Disclosure

SEC source: 0001209191-19-023427 · doc4.xml · derivative · entry 4

Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 367,355

Underlying: Class A Common Stock · 7,645 shares

Expires 2023-02-01

F6 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 7,645 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock. With respect to the remaining 367,355 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award.

F6 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 7,645 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock. With respect to the remaining 367,355 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award.

F6 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 7,645 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock. With respect to the remaining 367,355 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award.

F4 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:08 UTC
Hecht Peter MDirector · Chief Executive Officer
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 7,533 Not disclosed Strike: $13.11 Not disclosed
Disclosure

SEC source: 0001209191-19-023427 · doc4.xml · derivative · entry 3

Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,467

Underlying: Class A Common Stock · 7,533 shares

Expires 2022-02-01

F5 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 7,533 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock. With respect to the remaining 292,467 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award.

F5 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 7,533 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock. With respect to the remaining 292,467 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award.

F5 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 7,533 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock. With respect to the remaining 292,467 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award.

F4 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:08 UTC
Hecht Peter MDirector · Chief Executive Officer
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 44,020 Not disclosed Strike: $9.89 Not disclosed
Disclosure

SEC source: 0001209191-19-023427 · doc4.xml · derivative · entry 2

Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,980

Underlying: Class A Common Stock · 44,020 shares

Expires 2021-02-01

F3 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 44,020 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock. With respect to the remaining 130,980 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award.

F3 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 44,020 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock. With respect to the remaining 130,980 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award.

F3 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 44,020 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock. With respect to the remaining 130,980 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award.

F4 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:08 UTC
Hecht Peter MDirector · Chief Executive Officer
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 20,000 Not disclosed Strike: $4.88 Not disclosed
Disclosure

SEC source: 0001209191-19-023427 · doc4.xml · derivative · entry 1

Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Class A Common Stock · 20,000 shares

Expires 2019-07-28

F1 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"). In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F1 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"). In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F1 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"). In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F2 · derivative.exercise_date: The remaining 20,000 shares are presently exercisable in full.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 18:15 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 504 Not disclosed Strike: $12.56 Not disclosed
Disclosure

SEC source: 0001209191-19-023433 · doc4.xml · derivative · entry 10

MCCOURT Thomas A · CIK 0001478448 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,504

Underlying: Class A Common Stock · 504 shares

Expires 2024-03-03

F2 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F2 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F2 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F8 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 18:15 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 962 Not disclosed Strike: $11.65 Not disclosed
Disclosure

SEC source: 0001209191-19-023433 · doc4.xml · derivative · entry 9

MCCOURT Thomas A · CIK 0001478448 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,962

Underlying: Class A Common Stock · 962 shares

Expires 2023-02-01

F2 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F2 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F2 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F8 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 18:15 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 971 Not disclosed Strike: $13.11 Not disclosed
Disclosure

SEC source: 0001209191-19-023433 · doc4.xml · derivative · entry 8

MCCOURT Thomas A · CIK 0001478448 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,971

Underlying: Class A Common Stock · 971 shares

Expires 2022-02-01

F2 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F2 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F2 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F8 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 18:15 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 4,988 Not disclosed Strike: $9.89 Not disclosed
Disclosure

SEC source: 0001209191-19-023433 · doc4.xml · derivative · entry 7

MCCOURT Thomas A · CIK 0001478448 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,988

Underlying: Class A Common Stock · 4,988 shares

Expires 2021-02-01

F2 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F2 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F2 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F8 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 18:15 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 4,944 Not disclosed Strike: $4.88 Not disclosed
Disclosure

SEC source: 0001209191-19-023433 · doc4.xml · derivative · entry 6

MCCOURT Thomas A · CIK 0001478448 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,944

Underlying: Class A Common Stock · 4,944 shares

Expires 2019-09-07

F2 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F2 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F2 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F7 · derivative.exercise_date: The option vests as to 44,944 shares, as adjusted, upon the Issuer's achievement of a certain milestone. The remaining shares underlying the option are presently exercisable in full.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 18:15 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 39,982 Not disclosed Strike: $11.49 Not disclosed
Disclosure

SEC source: 0001209191-19-023433 · doc4.xml · derivative · entry 5

MCCOURT Thomas A · CIK 0001478448 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 384,982

Underlying: Class A Common Stock · 39,982 shares

Expires 2029-01-29

F2 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F2 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F2 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F6 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2019

Read SEC document
April 01, 2019 Filed Apr 3, 2019 18:15 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 11,154 Not disclosed Strike: $12.95 Not disclosed
Disclosure

SEC source: 0001209191-19-023433 · doc4.xml · derivative · entry 4

MCCOURT Thomas A · CIK 0001478448 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,404

Underlying: Class A Common Stock · 11,154 shares

Expires 2028-02-21

F2 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F2 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F2 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F5 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2018.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 18:15 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 8,518 Not disclosed Strike: $14.93 Not disclosed
Disclosure

SEC source: 0001209191-19-023433 · doc4.xml · derivative · entry 3

MCCOURT Thomas A · CIK 0001478448 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,018

Underlying: Class A Common Stock · 8,518 shares

Expires 2027-02-27

F2 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F2 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F2 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F4 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2017.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 18:15 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 4,056 Not disclosed Strike: $9.12 Not disclosed
Disclosure

SEC source: 0001209191-19-023433 · doc4.xml · derivative · entry 2

MCCOURT Thomas A · CIK 0001478448 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 179,056

Underlying: Class A Common Stock · 4,056 shares

Expires 2026-03-01

F2 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F2 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F2 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F3 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2016.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 18:15 UTC GrantClass A Common Stock 5,133 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-023433 · doc4.xml · nonDerivative · entry 1

MCCOURT Thomas A · CIK 0001478448 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,442

F1 · price: In connection with the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"), the reporting person received 5,133 restricted stock units as a result of the adjustment of existing Ironwood restricted stock units held by the reporting person prior to the Separation. The restricted stock units are subject to vesting conditions consistent with the terms of the existing Ironwood restricted stock units held by the reporting person prior to the Separation.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:17 UTC Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 562,500 Not disclosed Strike: $11.49 Not disclosed
Disclosure

SEC source: 0001209191-19-023438 · doc4.xml · derivative · entry 12

Currie Mark G · CIK 0001478244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Class A Common Stock · 562,500 shares

Expires 2029-01-29

F8 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F8 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F8 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F12 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2019.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:17 UTC Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 147,813 Not disclosed Strike: $12.95 Not disclosed
Disclosure

SEC source: 0001209191-19-023438 · doc4.xml · derivative · entry 11

Currie Mark G · CIK 0001478244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,187

Underlying: Class A Common Stock · 147,813 shares

Expires 2028-02-21

F8 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F8 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F8 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F11 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2018.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:17 UTC Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 109,375 Not disclosed Strike: $14.93 Not disclosed
Disclosure

SEC source: 0001209191-19-023438 · doc4.xml · derivative · entry 10

Currie Mark G · CIK 0001478244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,625

Underlying: Class A Common Stock · 109,375 shares

Expires 2027-02-27

F8 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F8 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F8 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F10 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2017.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:17 UTC Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 44,063 Not disclosed Strike: $9.12 Not disclosed
Disclosure

SEC source: 0001209191-19-023438 · doc4.xml · derivative · entry 9

Currie Mark G · CIK 0001478244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,707

Underlying: Class A Common Stock · 44,063 shares

Expires 2026-03-01

F8 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F8 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F8 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock. The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award.

F9 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2016.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:17 UTC Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 1,771 Not disclosed Strike: $12.56 Not disclosed
Disclosure

SEC source: 0001209191-19-023438 · doc4.xml · derivative · entry 8

Currie Mark G · CIK 0001478244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,229

Underlying: Class A Common Stock · 1,771 shares

Expires 2024-03-03

F7 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 1,771 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock. With respect to the remaining 83,229 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award.

F7 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 1,771 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock. With respect to the remaining 83,229 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award.

F7 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 1,771 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock. With respect to the remaining 83,229 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award.

F5 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:17 UTC Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 9,617 Not disclosed Strike: $11.65 Not disclosed
Disclosure

SEC source: 0001209191-19-023438 · doc4.xml · derivative · entry 7

Currie Mark G · CIK 0001478244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,383

Underlying: Class A Common Stock · 9,617 shares

Expires 2023-02-01

F6 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 9,617 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock. With respect to the remaining 190,383 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award.

F6 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 9,617 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock. With respect to the remaining 190,383 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award.

F6 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 9,617 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock. With respect to the remaining 190,383 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award.

F5 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:17 UTC Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 8,029 Not disclosed Strike: $13.11 Not disclosed
Disclosure

SEC source: 0001209191-19-023438 · doc4.xml · derivative · entry 6

Currie Mark G · CIK 0001478244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,971

Underlying: Class A Common Stock · 8,029 shares

Expires 2022-02-01

F4 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 8,029 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock. With respect to the remaining 101,971 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award.

F4 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 8,029 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock. With respect to the remaining 101,971 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award.

F4 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 8,029 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock. With respect to the remaining 101,971 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award.

F5 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:17 UTC Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 25,000 Not disclosed Strike: $15.62 Not disclosed
Disclosure

SEC source: 0001209191-19-023438 · doc4.xml · derivative · entry 5

Currie Mark G · CIK 0001478244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 25,000 shares

Expires 2025-03-16

F3 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.

F3 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.

F3 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.

F3 · derivative.exercise_date: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:17 UTC Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 41,041 Not disclosed Strike: $11.11 Not disclosed
Disclosure

SEC source: 0001209191-19-023438 · doc4.xml · derivative · entry 4

Currie Mark G · CIK 0001478244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 41,041 shares

Expires 2021-02-01

F3 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.

F3 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.

F3 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.

F3 · derivative.exercise_date: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:17 UTC Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 20,000 Not disclosed Strike: $5.48 Not disclosed
Disclosure

SEC source: 0001209191-19-023438 · doc4.xml · derivative · entry 3

Currie Mark G · CIK 0001478244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 20,000 shares

Expires 2019-07-28

F3 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.

F3 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.

F3 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.

F3 · derivative.exercise_date: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:17 UTC GrantClass A Common Stock 2,995 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-023438 · doc4.xml · nonDerivative · entry 2

Currie Mark G · CIK 0001478244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 532,958

F2 · kind: Issued pursuant to the Director Compensation Plan, effective as of January 2014.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:17 UTC GrantClass A Common Stock 1,483 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-023438 · doc4.xml · nonDerivative · entry 1

Currie Mark G · CIK 0001478244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 529,963

F1 · price: In connection with the separation (the "Separation"), of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"), the reporting person received 1,483 restricted stock units as a result of the adjustment of existing Ironwood restricted stock units held by the reporting person prior to the Separation. The award vests as shares of Class A Common Stock on May 9, 2019.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 23:06 UTC
Mallon MarkDirector · Chief Executive Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 423,049 $0.00 Strike: $14.02 $0.00
Disclosure

SEC source: 0001209191-19-023482 · doc4.xml · derivative · entry 4

Mallon Mark · CIK 0001763533 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 423,049

Underlying: Class A Common Stock · 423,049 shares

Expires 2029-04-01

F5 · derivative.exercise_date: The option, granted as a new Chief Executive Officer award, vests as to 25% of the shares of Class A Common Stock on the first anniversary of January 4, 2019 and 1/48th of the shares of Class A Common Stock vest each month thereafter for the next 36 months.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 23:06 UTC
Mallon MarkDirector · Chief Executive Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 21,203 Not disclosed Strike: $10.97 Not disclosed
Disclosure

SEC source: 0001209191-19-023482 · doc4.xml · derivative · entry 3

Mallon Mark · CIK 0001763533 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,729

Underlying: Class A Common Stock · 21,203 shares

Expires 2029-01-09

F3 · derivative.exercise_price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F3 · shares: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F3 · price: Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted to preserve the pre-Separation intrinsic value of the existing Ironwood option award.

F4 · derivative.exercise_date: The option, granted as a new hire award, vests as to 25% of the shares of Class A Common Stock on the first anniversary of January 4, 2019 and 1/48th of the shares of Class A Common Stock vest each month thereafter for the next 36 months.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 23:06 UTC
Mallon MarkDirector · Chief Executive Officer
GrantClass A Common Stock 206,873 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-023482 · doc4.xml · nonDerivative · entry 2

Mallon Mark · CIK 0001763533 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 311,409

F2 · kind: The restricted stock unit award, granted as a new hire award to the new Chief Executive Officer, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 23:06 UTC
Mallon MarkDirector · Chief Executive Officer
GrantClass A Common Stock 11,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-023482 · doc4.xml · nonDerivative · entry 1

Mallon Mark · CIK 0001763533 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,536

F1 · price: In connection with the separation (the "Separation") of Cyclerion Therapeutics, Inc. from Ironwood Pharmaceuticals, Inc. ("Ironwood"), the reporting person received 11,500 restricted stock units as a result of the adjustment of existing Ironwood restricted stock units held by the reporting person prior to the Separation. The restricted stock units are subject to vesting conditions consistent with the terms of the existing Ironwood restricted stock units held by the reporting person prior to the Separation.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:46 UTC GrantClass A Common Stock 2,995 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-023463 · doc4.xml · nonDerivative · entry 1

Moukheibir Catherine · CIK 0001772130 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,995

F1 · kind: Issued pursuant to the Director Compensation Plan, effective as of January 2014.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 22:42 UTC GrantClass A Common Stock 2,995 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-023459 · doc4.xml · nonDerivative · entry 1

Kessler Marla L · CIK 0001772124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,995

F1 · kind: Issued pursuant to the Director Compensation Plan, effective as of January 2014.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.